Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd.’s Net Profit Dropped 40.2% in First Half of 2023

Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd. (湖南达嘉维康医药产业股份有限公司) (301126.SZ) reported a net profit of 22.8 million yuan in the first half of 2023, down 40.2% year-on-year.

Meanwhile, the company posted 1.8 billion yuan in revenue, up 26.8% year-on-year.

At the end of the reporting period, it had 5 billion yuan in total assets and 3.1 billion yuan in total liabilities, with a liability-to-asset ratio of 62.8%.